277
Participants
Start Date
March 28, 2019
Primary Completion Date
February 1, 2021
Study Completion Date
November 3, 2021
Apremilast
Apremilast 30 mg tablets taken orally twice a day.
Placebo
Placebo tablets taken orally twice a day
Research Site, Lausanne
Research Site, Zurich
Research Site, Berlin
Research Site, Berlin
Research Site, Castellon
Research Site, Berlin
Research Site, Berlin
Research Site, Santiago de Compostela
Research Site, Genova
Research Site, Milan
Research Site, Hamburg
Research Site, Lübeck
Research Site, Kiel
Research Site, Valence
Research Site, Lugo
Research Site, Madrid
Research Site, Alcorcón
Research Site, Fuenlabrada
Research Site, Murcia
Research Site, Toulouse
Research Site, Bordeaux
Research Site, Marburg
Research Site, Salamanca
Research Site, Grenoble
Research Site, Bologna
Research Site, Seville
Research Site, Seville
Research Site, Saint-Priest-en-Jarez
Research Site, Bochum
Research Site, Manises
Research Site, Aachen
Research Site, Bonn
Research Site, Frankfurt am Main
Research Site, Heidelberg
Research Site, Lyon
Research Site, Valenciennes
Research Site, Tübingen
Research Site, Pringy
Research Site, Paris
Research Site, Rouen
Research Site, Napoli, Campania
Research Site, Napoli
Research Site, München
Research Site, Augsburg
Research Site, Ulm
Research Site, Langenau
Research Site, Erlangen
Research Site, Catania
Research Site, Gera
Research Site, Jena
Research Site, Perugia
Research Site, Roma
Research Site, Roma
Research Site, Badalona
Research Site, Alicante
Research Site, Barnet
Research Site, Birmingham
Research Site, Brighton
Research Site, Bury St Edmunds
Research Site, Dumfries
Research Site, Dundee
Research Site, Exeter
Research Site, Gloucester
Research Site, Isleworth
Research Site, Leeds
Research Site, London
Research Site, Newport
Research Site, Nottingham
Research Site, Plymouth
Research Site, Redhill
Research Site, Southampton
Research Site, Stourbridge
Lead Sponsor
Amgen
INDUSTRY